Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 40 Years to 75 Years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests whether reminders and tools in electronic health records help doctors and patients make yearly choices about PSA screening, a blood test used to check for prostate cancer. It is for men in the BJC Health System who meet age or cancer risk rules. The goal is to find fewer cancers at a late stage without finding more cancers that would never cause harm.
\- The investigators propose a clinical trial to evaluate the impact of annual shared decision making for PSA screening, supported by system-level enhancements to promote evidence-based care: * Defined referral thresholds within the health maintenance reminder, aligned with clinical risk stratification per NCCN guidelines. * Enhanced clinical decision support (CDS) tools to reduce provider variation and ensure guideline-concordant screening and referral practices. * The goal is to reduce late-stage presentation without increasing overdiagnosis-ensuring that prostate cancer screening is both accessible and clinically effective.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Get care within the BJC Health System.
- Have at least one visit with a primary care doctor in the same calendar year as PSA screening.
- Be male.
- Meet at least one of these risk rules: be African American and age 40–75; have a family history of prostate, breast, ovarian, or pancreatic cancer; have a known inherited gene change in your family; or be at average risk and age 50–75.
Who can't join
- Have a history of prostate cancer.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Eligibility Criteria: * Receive care within the BJC Health System * Have had at least one primary care physician appointment in the calendar year of PSA screening (primary care) * Be male * Not have a history of prostate cancer * Meet one of the following risk criteria: * High Risk for Prostate Cancer * African American, between the ages of 40 and 75 (inclusive), or * Family history of prostate, breast, ovarian, and/or pancreatic cancer, or * Known familial germline mutation OR * Average Risk for Prostate Cancer * Between the ages of 50 and 75 (inclusive)
Study sites (1)
MO
- Washington University School of Medicine · St Louis, MO 63110Lannis Hall, M.D., MPH · Study contact · 636-916-9947 · lannishall@wustl.eduLannis Hall, M.D., MPH · Principal investigatorSaira Khan, Ph.D., MPH · Sub-investigatorArnold Bullock, M.D. · Sub-investigatorMore trials in St Louis